Sickle Cell Disease in the Post Genomic Era: A Monogenic Disease with a Polygenic Phenotype
Sickle Cell Disease in the Post Genomic Era: A Monogenic Disease with a Polygenic Phenotype
复制标题
DOI:
10.4137/gei.s2626
复制
发表时间:
2009-07
期刊:
影响因子:
--
通讯作者:
Adel Driss;Kwaku Asare;J. Hibbert;Beatrice E. Gee;Tom Adamkiewicz;Jonathan K. Stiles
中科院分区:
文献类型:
--
作者:
Adel Driss;Kwaku Asare;J. Hibbert;Beatrice E. Gee;Tom Adamkiewicz;Jonathan K. Stiles
More than half a century after the discovery of the molecular basis of Sickle Cell Disease (SCD), the causes of the phenotypic heterogeneity of the disease remain unclear. This heterogeneity manifests with different clinical outcomes such as stroke, vaso-occlusive episodes, acute chest syndrome, avascular necrosis, leg ulcers, priapism and retinopathy. These outcomes cannot be explained by the single mutation in the beta-globin gene alone but may be attributed to genetic modifiers and environmental effects. Recent advances in the post human genome sequence era have opened the door for the identification of novel genetic modifiers in SCD. Studies are showing that phenotypes of SCD seem to be modulated by polymorphisms in genes that are involved in inflammation, cell–cell interaction and modulators of oxidant injury and nitric oxide biology. The discovery of genes implicated in different phenotypes will help understanding of the physiopathology of the disease and aid in establishing targeted cures. However, caution is needed in asserting that genetic modifiers are the cause of all SCD phenotypes, because there are other factors such as genetic background of the population, environmental components, socio-economics and psychology that can play significant roles in the clinical heterogeneity.